drugset / Trial / NCT05121168
Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, triple-masked, placebo-controlled parallel-arm human subjects clinical trial investigating the addition of a continuous erector spinae plane nerve block to a single-injection erector spinae plane block to provide postoperative analgesia following percutaneous nephrolithotomy. Participants will all receive a single-injection nerve block and perineural catheter insertion. Following surgery, participants will be randomly allocated to receive either perineural local anesthetic or normal saline until the second day following surgery.
Timeline
- Start
- 2022-03-16
- Primary completion
- 2025-11-06
- Completion
- 2025-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | Other |